Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)
- Empirical Formula: C27H31D5N2O11
- Molecular Weight: 0
- Update Date: 2023-04-23 13:52:06
What is Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)?
The Uses of Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)
A labelled metabolite of Ramipril (R111000).
Properties of Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)
| solubility | Dimethyl Sulfoxide |
Safety information for Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)
Computed Descriptors for Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers)
New Products
9-Mesityl-10-methylacridinium perchlorate Sulfapyridine Fmoc-OSu (R)-(-)-2-Amino-1-propanol Cyclobutanone 5-bromo-4-fluoro-2-nitrobenzaldehyde 4 pentyn 1 ol N-Vinylformamide Phenethyl cinnamate Pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, 4,6,7,8-tetrahydro-4-oxo-, sodium salt (1:1), (6S) Ethyl 3-phenylpropanoate β-Bromostyrene Methacrylate-PEG-Methacrylate, Mn:35000 2,4-Dihydroxyacetophenone 2-Chloro 5-Fluoro Pyridine Vasicinone 2-Chloroisonicotinic Acid Tween 80 or Polysorbate 80 Methyl trans-4-Aminocyclohexanecarboxylate Hydrochloride N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine Pirtobrutinib intd. 4-Nitrobenzotrifluoride 2-Pentyn-1-oL N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamideYou may like
-
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
213382-45-7 98+View Details
213382-45-7 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1 -
1191-95-3 Cyclobutanone 98+View Details
1191-95-3 -
213382-45-7 98+View Details
213382-45-7 -
Fmoc-OSu 98+View Details
82911-69-1 -
(R)-(-)-2-Amino-1-propanol 35320-23-1 98+View Details
35320-23-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.